V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20193700 | 20124372 | 1.66 | 92.5 | Adjuvant (A) | 2019-11-14 | 2019-11-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100188232 |
| 20193707 | 20124373 | 1.7 | 68.3 | Palliative (P) | 2017-07-13 | 2018-09-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100138015 |
| 20193710 | 20124374 | 1.54 | 68.4 | Palliative (P) | 2017-06-01 | 2018-02-27 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100833759 |
| 20193712 | 20124375 | 1.61 | 85.3 | null | 2018-06-09 | 2019-02-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100200484 |
| 20193715 | 20124376 | 1.85 | 50.7 | Palliative (P) | 2019-01-23 | 2019-04-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100937527 |
| 20193720 | 20124377 | 1.66 | 115.7 | null | 2018-03-28 | 2018-03-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101335437 |
| 20193725 | 20124378 | 1.74 | 86.7 | null | 2017-07-11 | 2017-07-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101115578 |
| 20193727 | 20124379 | 1.61 | 72 | Curative (C) | 2019-05-17 | 2019-05-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100608900 |
| 20193729 | 20124380 | 1.67 | 71.3 | null | 2019-02-25 | 2019-03-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100032607 |
| 20193732 | 20124381 | 1.63 | 75 | null | 2018-07-20 | 2018-07-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101139042 |
| 20193739 | 20124382 | 1.51 | 67.6 | Palliative (P) | 2017-10-18 | 2017-10-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101302341 |
| 20193741 | 20124383 | 1.93 | 65.8 | null | 2017-12-17 | 2017-12-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101318864 |
| 20193743 | 20124384 | 1.69 | 46 | Adjuvant (A) | 2016-10-16 | 2017-05-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100178368 |
| 20193744 | 20124385 | 1.6 | 61 | null | 2018-01-09 | 2018-01-22 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101491754 |
| 20193749 | 20124386 | null | 46 | Palliative (P) | 2019-09-14 | 2019-10-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100434571 |
| 20193751 | 20124387 | 1.61 | 98.8 | Neo-adjuvant (N) | null | 2019-09-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101035304 |
| 20193753 | 20124388 | 1.6 | 75.75 | Neo-adjuvant (N) | 2021-02-04 | 2021-08-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100428807 |
| 20193754 | 20124389 | 1.7 | 82.2 | Palliative (P) | 2017-10-03 | 2017-10-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100780688 |
| 20193755 | 20124390 | 1.76 | 54.4 | Palliative (P) | 2018-07-08 | 2018-07-08 | Docetaxel | 02 | N | DOCETAXEL | 100864101 |
| 20193756 | 20124391 | 1.7 | 83.6 | Adjuvant (A) | 2017-05-27 | 2017-05-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101429568 |
| 20193757 | 20124392 | 1.71 | 65.3 | Palliative (P) | 2021-01-06 | 2021-01-06 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100514079 |
| 20193760 | 20124393 | 1.62 | 88 | Palliative (P) | 2016-01-20 | 2016-10-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101177858 |
| 20193763 | 20124394 | 1.61 | 62.5 | Palliative (P) | 2018-08-28 | 2018-08-31 | Docetaxel 75mg/m2 (21 day) | 02 | Y | DOCETAXEL | 100473702 |
| 20193770 | 20124395 | 1.6 | 45.8 | Palliative (P) | 2019-04-04 | 2019-04-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101796898 |
| 20193775 | 20124396 | 1.54 | 68 | Palliative (P) | null | 2019-10-11 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101855655 |
| 20193776 | 20124397 | 1.9 | 112.3 | null | 2019-10-13 | 2019-12-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101141934 |
| 20193777 | 20124398 | 1.85 | 79.3 | null | 2020-01-08 | 2020-01-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100915675 |
| 20193778 | 20124399 | 1.93 | 95 | Palliative (P) | 2019-06-17 | 2019-08-01 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100471210 |
| 20193780 | 20124400 | 1.76 | 55.4 | null | 2016-07-30 | 2016-08-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101701758 |
| 20193791 | 20124401 | 1.47 | 56.1 | Palliative (P) | 2018-08-12 | 2018-08-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100523936 |
| 20193795 | 20124402 | 1.88 | 75 | Palliative (P) | 2020-12-17 | 2020-12-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100125071 |
| 20193796 | 20124403 | 1.82 | 74.7 | null | 2018-02-20 | 2018-02-27 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101722307 |
| 20193797 | 20124404 | 1.6 | 80 | Palliative (P) | 2016-09-21 | 2016-10-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100604380 |
| 20193799 | 20124405 | 1.55 | 66.6 | null | 2017-10-14 | 2017-10-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101490617 |
| 20193800 | 20124406 | 1.76 | 48.2 | null | 2017-12-26 | 2017-12-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100744373 |
| 20193808 | 20124407 | 1.7 | 69 | null | 2017-04-05 | 2017-04-28 | Gemcitabine + Capecitabine | null | null | CAPECITABINE + GEMCITABINE | 101287114 |
| 20193811 | 20124408 | 1.69 | 82 | Palliative (P) | 2018-08-05 | 2018-08-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100353041 |
| 20193816 | 20124409 | 1.61 | 89 | null | 2020-01-12 | 2020-01-22 | Docetaxel | 02 | null | DOCETAXEL | 100567206 |
| 20193817 | 20124410 | 1.52 | 62 | null | 2017-11-19 | 2017-11-25 | Docetaxel | null | null | DOCETAXEL | 100287314 |
| 20193819 | 20124411 | 1.75 | 69.7 | Palliative (P) | 2016-04-05 | 2016-04-17 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101155901 |
| 20193824 | 20124412 | 1.66 | 97.7 | Palliative (P) | 2020-07-29 | 2020-08-05 | Docetaxel | N | N | DOCETAXEL | 100855383 |
| 20193829 | 20124413 | 1.78 | 46 | Palliative (P) | null | 2017-03-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101247372 |
| 20193833 | 20124414 | 1.57 | 68 | Palliative (P) | 2020-07-18 | 2020-07-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100825062 |
| 20193840 | 20124415 | 1.61 | 95 | Palliative (P) | 2018-05-16 | 2018-12-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101794620 |
| 20193841 | 20124416 | 1.78 | 81.5 | Palliative (P) | 2019-09-06 | 2019-09-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101832898 |
| 20193848 | 20124417 | 1.7 | 71.7 | Palliative (P) | 2018-06-24 | 2018-07-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100281421 |
| 20193850 | 20124418 | 1.73 | 83 | Palliative (P) | 2019-11-17 | 2020-03-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101632484 |
| 20193851 | 20124419 | null | 85 | Palliative (P) | 2019-05-03 | 2019-05-11 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100471970 |
| 20193852 | 20124420 | 1.6 | 60.2 | Curative (C) | 2020-08-08 | 2020-08-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101327961 |
| 20193854 | 20124421 | 1.69 | 67.7 | Palliative (P) | 2017-10-01 | 2017-10-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100497742 |